ITRM20050032A1 - Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica. - Google Patents

Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.

Info

Publication number
ITRM20050032A1
ITRM20050032A1 IT000032A ITRM20050032A ITRM20050032A1 IT RM20050032 A1 ITRM20050032 A1 IT RM20050032A1 IT 000032 A IT000032 A IT 000032A IT RM20050032 A ITRM20050032 A IT RM20050032A IT RM20050032 A1 ITRM20050032 A1 IT RM20050032A1
Authority
IT
Italy
Prior art keywords
hmgb1
antagonists
progression
inhibitors
aterosclerotic
Prior art date
Application number
IT000032A
Other languages
English (en)
Inventor
Marco E Bianchi
Roberta Palumbo
Annalisa Porto
Original Assignee
Marco E Bianchi
Bio3 Res S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marco E Bianchi, Bio3 Res S R L filed Critical Marco E Bianchi
Priority to IT000032A priority Critical patent/ITRM20050032A1/it
Priority to PCT/IT2006/000027 priority patent/WO2006077614A1/en
Publication of ITRM20050032A1 publication Critical patent/ITRM20050032A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
IT000032A 2005-01-21 2005-01-21 Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica. ITRM20050032A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT000032A ITRM20050032A1 (it) 2005-01-21 2005-01-21 Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
PCT/IT2006/000027 WO2006077614A1 (en) 2005-01-21 2006-01-18 Hmgb1 inhibitors and antagonists for the inhibition of atherosclerosis pathogenesis and development

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000032A ITRM20050032A1 (it) 2005-01-21 2005-01-21 Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.

Publications (1)

Publication Number Publication Date
ITRM20050032A1 true ITRM20050032A1 (it) 2006-07-22

Family

ID=36218422

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000032A ITRM20050032A1 (it) 2005-01-21 2005-01-21 Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.

Country Status (2)

Country Link
IT (1) ITRM20050032A1 (it)
WO (1) WO2006077614A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2519714C2 (ru) 2008-04-30 2014-06-20 Дженомикс Ко., Лтд. Средство для вовлечения происходящей из костного мозга плюрипотентной стволовой клетки в периферический кровоток
KR20160070169A (ko) 2008-04-30 2016-06-17 가부시키가이샤 제노믹스 생체내 기능적 세포의 고효율 채취법
CA2778759A1 (en) 2009-10-28 2011-05-05 Genomix Co., Ltd. Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
CA2834255C (en) 2011-04-26 2021-11-02 Genomix Co., Ltd. Peptide for inducing regeneration of tissue and use thereof
TR201807769T4 (tr) 2012-10-25 2018-06-21 Genomix Co Ltd HMGB1 fragmanı kullanılarak spinal kord yaralanmasının tedavi edilmesine yönelik yeni yöntem.
AU2013335684B2 (en) 2012-10-25 2017-06-29 Osaka University Novel method for treating cardiac infarction using HMGB1 fragment
TWI805565B (zh) 2017-01-27 2023-06-21 日商斯德武利姆股份有限公司 心肌病、陳舊性心肌梗塞及慢性心臟衰竭的治療藥物
EP3718561A4 (en) 2017-12-01 2021-07-21 Stemrim Inc. Therapy for inflammatory bowel disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
ITMI20010562A1 (it) * 2001-03-16 2002-09-16 Marco E Bianchi Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari

Also Published As

Publication number Publication date
WO2006077614A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
ITRM20050032A1 (it) Inibitori ed antagonisti di hmgb1 in grado di inibire la patogenesi e la progressione della malattia aterosclerotica.
DK1954140T3 (da) Glycerollevulinatketaler og deres anvendelse
DK1720866T3 (da) Fremgangsmåde
ITMO20050067A1 (it) Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
IS8596A (is) Mótefni gegn CD154
JP2006122056A5 (ja) β-グルカンの使用
DK1937276T3 (da) Forbedret testosterongel og fremgangsmåde til anvendelse deraf
ITVR20060060A1 (it) Struttura di seggiolone
DE602005018854D1 (de) Gerät um Kontaktkorrosion vorzubeugen
DE602005005523D1 (de) Abgasrohrstruktur
BRPI0716893A2 (pt) Forma de dosagem sólida de olmesartan medoxomila e anlodipina
FI20050195A (fi) Metalliseoksen käyttö
DK2124997T3 (da) Anvendelse af IL-1-antagonister til behandling af gigt og pseudogigt
DE602006016400D1 (de) Damit
ITRM20040058A1 (it) Inibitori ed antagonisti di hmgb1 in grado di regolare la proliferazione delle cellule muscolari lisce ed endoteliali.
DK2975139T3 (da) Assay til at detektere og kvantificere hiv-1
DE502005009677D1 (de) Ringstruktur in metallbauweise mit einlaufbelag
ITVR20040025A1 (it) Struttura di letto
ITVR20050001U1 (it) Struttura di seggiolone
ITMI20052231A1 (it) Struttura perfezionata di espansore rapido del palato
ITMI20042348A1 (it) Struttura di pattino in linea
FI20051338A (fi) Kararakenne palloventtiilissä
ES1060969Y (es) Refugio y criadero de conejos.
ITVR20050140A1 (it) Struttura di tramezzo
ITVR20050133A1 (it) Struttura di monile